Keyphrases
18F-fluorodeoxyglucose (18F-FDG)
100%
18F-fluorodeoxyglucose PET
33%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
16%
Borderline Resectable
16%
Cancer Patients
33%
Chemoradiotherapy
50%
Fluorodeoxyglucose Uptake
100%
Glucose Uptake
16%
Glycolysis
16%
Induction Chemotherapy
66%
Initial Diagnosis
16%
Metabolic Shift
16%
Multivariate Analysis
33%
Optimal Cutoff
16%
Overall Survival
50%
Pancreatic Cancer
100%
Partial Response
50%
Progressive Disease
16%
Radioresistance
16%
Response Rate
33%
Response to Chemoradiotherapy
100%
Stable Disease
16%
Standardized Uptake Value
16%
Surgical Resection
16%
SUVmax
100%
Therapeutic Response
33%
Tumor
50%
Tumor Response Rate
16%
Medicine and Dentistry
Chemoradiotherapy
100%
Disease
16%
Fluorodeoxyglucose
33%
Fluorodeoxyglucose F 18
100%
Glucose Uptake
16%
Induction Chemotherapy
66%
Multivariate Analysis
33%
Neoplasm
66%
Overall Survival
50%
Pancreas Cancer
100%
Positron Emission Tomography
33%
Positron Emission Tomography
16%
Progressive Disease
16%
Radiosensitivity
16%
Standardized Uptake Value
16%
Surgery
16%
Treatment Response
33%
Immunology and Microbiology
Glucose Transport
33%
Overall Survival
100%
Positron Emission Tomography
33%
Radioresistance
33%